PuSH - Publication Server of Helmholtz Zentrum München

Guan, C.* ; Li, C.* ; Yang, C.* ; Yang, D.* ; Zhang, L.* ; Xu, L.* ; Liu, K.* ; Zhang, N.* ; Li, T.* ; Song, Z.* ; Che, L.* ; Wang, Y.* ; Zhang, L. ; Li, D.* ; Zhu, Y.* ; Xu, Y.*

Enhanced renal carcinomat treatment via synergistic photothermal/photodynamic therapy using hittorf's phosphorus-decorated polymeric carbon nitride heterostructure.

Adv. Opt. Mater. 2024:2303318 (2024)
Publ. Version/Full Text DOI
Open Access Hybrid
Creative Commons Lizenzvertrag
Nanostructured heterojunctions offer a promising solution to overcome the limitations of narrow absorption spectra, limited penetration depths, and potential harm to healthy cells in phototherapy for clear cell renal cell carcinoma (ccRCC) treatment with nanomaterials. In this study, a heterostructure (PCN@HP) by decorating Hittorf's phosphorus nanorods onto biocompatible polymeric carbon nitride (PCN), enabling excitation by NIR light is designed. Compared with PCN and HP alone, the synthesized heterostructure generated localized heat upon broad absorption spectra of irradiation, boosting charge migration and separation, generating cytotoxic reactive oxygen species (ROS). Then, via in vitro and in vivo experiments, it is confirmed that the NIR-mediated PCN@HP heterojunction is a safe and effective approach for synchronous photothermal and photodynamic therapy treatment of ccRCC. Collectively, the PCN@HP heterojunction holds great potential as a non-invasive synergistic, dual-mode therapeutic nanomedicine for efficient tumor nano-therapy.
Impact Factor
Scopus SNIP
Altmetric
8.000
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Clear Cell Renal Cell Carcinoma ; Hittorf's Phosphorus ; Mild Photothermal Therapy ; Photodynamic Therapy; Photothermal Therapy; Cell Carcinoma; Photodynamic Therapy; Tumor; Nanoparticles; Nanomaterials; Resistance
Language english
Publication Year 2024
HGF-reported in Year 2024
ISSN (print) / ISBN 2195-1071
e-ISSN 2195-1071
Quellenangaben Volume: 2024, Issue: , Pages: , Article Number: 2303318 Supplement: ,
Publisher Wiley
Publishing Place Postfach 101161, 69451 Weinheim, Germany
Reviewing status Peer reviewed
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502300-001
Scopus ID 85186580360
Erfassungsdatum 2024-05-08